Edwards Lifesciences Corp - Common Stock (EW)

CUSIP: 28176E108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
590,231,680
Total 13F shares
514,695,199
Share change
-2,239,247
Total reported value
$66,609,194,753
Put/Call ratio
99%
Price per share
$129.55
Number of holders
1,305
Value change
-$186,675,822
Number of buys
563
Number of sells
510

Quarterly Holders Quick Answers

What is CUSIP 28176E108?
CUSIP 28176E108 identifies EW - Edwards Lifesciences Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2021

As of 31 Dec 2021, Edwards Lifesciences Corp - Common Stock (EW) was held by 1,305 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 514,695,199 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Bank of New York Mellon Corp, Capital International Investors, BROWN ADVISORY INC, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., SANDS CAPITAL MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 1,307 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.